The prevalence of SARS-coV-2 infection in a public university of Paraná: an observational study
Abstract
Introduction: COVID-19 is a disease caused by the SARS-CoV-2 virus that spread worldwide in early 2020. One year and seven months after the beginning of the global spread of the disease, the number of confirmed cases in Brazil exceeds 21 million and 601 thousand deaths recorded. The aim of this study was to assess the prevalence of SARS-CoV-2 infection in an academic community.
Method: Observational study, with a cross-sectional design, carried out in the academic community of a Public State University in Northern Paraná. 157 people participated, including professors, academics and university agents. The dependent variable was the presence of total antibodies against SARS-CoV-2.
Results: The prevalence of antibodies against SARS-CoV-2 in academics and employees of a public university in the North region of Paraná was 7%. In the bivariate analysis of factors associated with the presence of antibodies, teachers, people who had close contact with a confirmed case of COVID-19, fever, muscle pain, cough, sore throat, anosmia and ageusia, were the characteristics that were most associated with the disease. presence of antibodies.
Conclusion: It was found that 7% of the academic community studied had antibodies against COVID-19.
Downloads
References
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19 [Internet]. Nature reviews. Microbiology. 2021;19(3):141–54.
Organização panamericana de saúde (OPAS). OMS afirma que COVID-19 é agora caracterizada como pandemia. [acesso em 14 out. 2021] Disponível em: https://www.paho.org/pt/news/11-3-2020-who-characterizes-covid-19-pandemic.
John Hopkins University - Coronavirus Resources Center [acesso em 14 out 2021]. Disponível em: https://coronavirus.jhu.edu/map.html.
MINISTÉRIO DA SAÚDE. Painel de casos COVID-19 [acesso em: 14 out 2021]. Disponível em: https://covid.saude.gov.br/.
Dias VMCH, Carneiro M, Michelin L, Vidal CFL, Costa LATJC, Ferreira CES, et al. Testes sorológicos para COVID-19: Interpretação e aplicações práticas. J. Infect. Control. 2020; 9(2).
MINISTÉRIO SA SAÚDE. Como se proteger? Confira medidas não farmacológicas de prevenção e controle da pandemia do novo coronavírus [acesso em 19 jul 2021]. Disponível em: https://www.gov.br/saude/pt-br/coronavirus/como-se-proteger.
CEPEDES/ENSP/FIOCRUZ. A gestão de riscos e governança na pandemia por COVID-19 no Brasil: análise dos decretos estaduais no primeiro mês, relatório técnico e sumário executivo. Rio de Janeiro: Fiocruz; 2020 [acesso em 14 out 2021]. Disponível em: https://www.arca.fiocruz.br/bitstream/icict/41452/2/relatorio_cepedes_gestao_riscos_covid19_final.pdf
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Guia para Investigações de Surtos ou Epidemias / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis – Brasília : Ministério da Saúde, 2018 [acesso em 14 out 2021]. Disponível em: https://portalarquivos2.saude.gov.br/images/pdf/2018/novembro/21/guia-investigacao-surtos-epidemias-web.pdf
Jung CF. Metodologia científica: ênfase em pesquisa tecnológica. 3ª edição. 2003 [acesso em 14 out 2021]. Disponível em: https://d1wqtxts1xzle7.cloudfront.net/38222499/metodologia_cientifica...-with-cover-page-v2.pdf?Expires=1634262206&Signature=MYU~1Zzkfji2lAuDWwAoJMVc9IYtvAOTrTk~D19VrRgpPeVtRO40mGFT-fARjbekJY0TwNmI-4Mo-YxUldTsSNmGho2cmOpO4Usr-ASoX-Dqs9BY1DO7WDLke0JfyFVIoy-pcph64ZGWpBlGZbU8tXH9xk~th4uNfO1uYb09Jp-EVZ7n9C3XzbxvCCUzg88MCad5dDiaYYeFcfborD~kh5ps~5ymW3~0DjY370yToIXl4hEpV0XZjc60YNR1cHO6RY2vsbr6w-ioWp07sA5b0lPn7lQhlh3bSaCB81vct7irlhZCLE-3R4p6~ohJI0mTym~DDgtGqMJiNQSb7eYFlQ__&Key-Pair-Id=APKAJLOHF5GGSLRBV4ZA.
Moreira RC, Fernandes PHC. Jornal Geografia/UENP. Edição 37. 2020 [acesso em 14 out 2021]. Disponível em: https://sites.google.com/view/jornalgeografia/edi%C3%A7%C3%B5es?authuser=0
Moreira RC, Lizzi EAS, Santos ES, Zanatta LF, Galdino MJQ, André GV, et al. Serological survey for research of COVID-19 infections in The adult population of north pioneer, paraná-brazil. International Journal of Development Research. 2021;11(04):46551-5.
Epicobs. Estudo inédito reúne dados sobre Sars-CoV-2 na Baixada Santista. UNIFESP. 2020 [acesso em 14 out 2021]. Disponível em: https://www.unifesp.br/reitoria/dci/releases/item/4570-estudo-inedito-reune-dados-sobre-sars-cov-2-na-baixada-santista
Kislaya I, Gonçalves P, Barreto M, Sousa R, Garcia AC, Matos R, et al. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19). Acta Med Port. 2021 Fev 1;34(2):87-94.
Meireles P, Amaro J, Costa JP, Lopes MM, Varandas T, Norton P, et al. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study. Occup Environ Med. 2021 Set;78(9):648-653.
Rafael RMR, Correia LM, Mello AS, Prata JA, Gallasch CH, Pérez J, et al. Segurança e educação durante a COVID-19: prevalência, fatores associados e planos de reabertura da Faculdade de Enfermagem. Esc. Anna Nery Rev. Enfem. 2021;25.
Huamaní C, Velásquez L, Montes S, Mayanga-Herrera A, Bernabé-Ortiz A. SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study. PeerJ. 2021.
World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Geneva: World Health Organization; 2020[acesso em 15 out 2021]. Disponível em: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
Santos JFS, Santos DD. Hierarchy of Covid-19-Related Flu Symptoms According to Sex and Color or Race in Reports of Patients with Severe Acute Respiratory Syndrome in Brazil. Advances in Research. 2020;21(11), 67-78.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020 Abr;80(4):401-406.
Accorsi TAD, Amicis K, Brígido ARD, Belfort DSP, Habrum FC, Scarpanti FG, et al. Avaliação de pacientes com sintomas respiratórios agudos durante a pandemia de COVID-19 via Telemedicina: características clínicas e impacto no encaminhamento. Einstein. 2020;18:1-8.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Gasmi A, Peana M, Pivina L, Srinath S, Benahmed AG, Semenova Y, et al. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021 mar;224.
Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int. 2020 Abr 17;117(16):271-278.
Pang KW, Chee J, Subramaniam S, Ng LC. Frequency and Clinical Utility of Olfactory Dysfunction in COVID-19: a Systematic Review and Meta-analysis. Curr Allergy Asthma. 2020;20(76).
Aziz M, Goyal H, Haghbin H, Lee-Smith WM, Gajendran M, Perisetti A. The Association of "Loss of Smell" to COVID-19: A Systematic Review and Meta-Analysis. Am J Med Sci. 2021 Fev;361(2):216-225.
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 ago;277(8):2251-2261.
Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J Korean Med Sci. 2020 Mai 11;35(18):174.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
